|
- Design of an epitope-based peptide vaccine against Cryptococcus . . .
In this study, through in silico simulations, a multi-epitope vaccine against Cryptococcus neoformans was developed using the mannoprotein antigen (MP88) as a vaccine candidate
- Design of an epitope‐based peptide vaccine against Cryptococcus . . .
In this study we successfully designed multi-epitope vaccines for Cryptococcus neoformans targeting its immunogenic mannoprotein MP88 by using immunoinformatic tools
- Design of an epitope-based peptide vaccine againstCryptococcus neoformans
This study aimed to design an immunogenic epitope for Cryptococcus neoformans the etiological agent of cryptococcosis using in silico simulations, for epitope prediction, we selected the mannoprotein antigen MP88 which it’s known to induce protective immunity
- Design of an epitope-based peptide vaccine against Cryptococcus neoformans
Introduction This study aimed to design an immunogenic epitope for Cryptococcus neoformans the etiological agent of cryptococcosis using in silico simulations, for epitope prediction, we selected
- Design of an epitope-based peptide vaccine against Cryptococcus . . .
This successfully designed a peptide vaccine against Cryptococcus neoformans open up a new horizon in Cryptococcus neoformans research; the results require validation by in vitro and in vivo experiments
- Design of an epitope-based peptide vaccine. . . : FEBS Open Bio
In this study, through in silico simulations, a multi-epitope vaccine against Cryptococcus neoformans was developed using the mannoprotein antigen (MP88) as a vaccine candidate
- Design of an epitope‐based peptide vaccine against Cryptococcus neoformans
Through in silico simulations, a multi‐epitope vaccine against Cryptococcus neoformans was developed using the mannoprotein antigen (MP88) as a vaccine candidate and predicted to be antigenic, nontoxic, nonallergenic, soluble, stable, hydrophilic, and thermostable
- Design of an epitope‐based peptide vaccine against Cryptococcus neoformans
In this study we successfully designed multi-epitope vaccines for Cryptococcus neoformans targeting its immunogenic mannoprotein MP88 by using immu-noinformatic tools
|
|
|